Table 5:

History of antifungal therapy

TimeAll (n = 61), n (%)Relapse (n = 25), n (%)Non-relapse (n = 36), n (%)P-value*
Any point before surgery29 (48)6 (24)23 (64)0.002
 Within 6 months21 (34)5 (20)16 (44)0.048
 Perioperative24 (39)5 (20)19 (53)0.010
After surgery36 (59)12 (48)24 (67)0.15
Before and after surgery25 (59)5 (48)20 (67)0.005
Any point related to surgery40 (66)13 (52)27 (75)0.063
TimeAll (n = 61), n (%)Relapse (n = 25), n (%)Non-relapse (n = 36), n (%)P-value*
Any point before surgery29 (48)6 (24)23 (64)0.002
 Within 6 months21 (34)5 (20)16 (44)0.048
 Perioperative24 (39)5 (20)19 (53)0.010
After surgery36 (59)12 (48)24 (67)0.15
Before and after surgery25 (59)5 (48)20 (67)0.005
Any point related to surgery40 (66)13 (52)27 (75)0.063
*

P-values <0.0083 were considered statistically significant.

Table 5:

History of antifungal therapy

TimeAll (n = 61), n (%)Relapse (n = 25), n (%)Non-relapse (n = 36), n (%)P-value*
Any point before surgery29 (48)6 (24)23 (64)0.002
 Within 6 months21 (34)5 (20)16 (44)0.048
 Perioperative24 (39)5 (20)19 (53)0.010
After surgery36 (59)12 (48)24 (67)0.15
Before and after surgery25 (59)5 (48)20 (67)0.005
Any point related to surgery40 (66)13 (52)27 (75)0.063
TimeAll (n = 61), n (%)Relapse (n = 25), n (%)Non-relapse (n = 36), n (%)P-value*
Any point before surgery29 (48)6 (24)23 (64)0.002
 Within 6 months21 (34)5 (20)16 (44)0.048
 Perioperative24 (39)5 (20)19 (53)0.010
After surgery36 (59)12 (48)24 (67)0.15
Before and after surgery25 (59)5 (48)20 (67)0.005
Any point related to surgery40 (66)13 (52)27 (75)0.063
*

P-values <0.0083 were considered statistically significant.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close